Zusammenfassung
Die Prävalenz der koronaren Herzkrankheit (KHK) ist unabhängig vom Geschlecht eng mit den folgenden Risikofaktoren verbunden:
-
Alter,
-
genetische Belastung,
-
Rauchen,
-
Hypertonie,
-
Dyslipidä und
-
Diabetes mellitus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Anderson KM, Wilson PW, Odell PM, Kannel WB (1991) An updated coronary risk profile. Circulation 83:357–363
Austin MA, Shelby JV (1995) LDL subclass phenotypes and the risk factors of the insulin resistance syndrome. Int J Obes 19(Suppll):S22–26
Barrett-Connor E, Wingard D L (1983) Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 118:489–496
Berlin JA, Colditz GA (1990) A meta-analysis of physical activity in the prevention of coronary he art disease. Am J Epidemiol 132:612–628
Bittner V, Oparil S (1993) Hypertension. In: Douglas PS (ed) Cardiovascular health and disease in women. Saunders, Philadelphia, p 63
Birdsall MA, Farquhar CM, White HD (1997) Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med 126:32–35
Bostom AG, Gagnon DR, Cuppies A et al. (1994) A prospective investigation of elevated lipoprotein a detectedby electrophoresis and cardiovascular disease in women: The Framingham he art study. Circulation 90:1688
Castelli WP, Garrison RJ, Wilson PWF et al. (1986) Incidence of coronary heart disease and lipoprotein cholesterollevels: The Framingham study. JAMA 256:2835–2838
Centers of Disease Control (1992) Coronary heart disease incidence by sex - United States. MMWR Morb Mortal Wkly Rep 41(SS-2):526
Coleman MP, Key TJA, Wang EY et al. (1992) A prospective study of obesity, lipids, apolipoproteins and ischaemic heart disease in women. Artherosclerosis 92:177–185
Criqui MH, Heiss G, Cohn R et al. (1993) Plasma triglycerides level and mortality from coronary heart disease. N Engl J Med 328:1220–1225
Denke MA (1999) Primary prevention of coronary heart disease in postmenopausal women. Am J Med 107 (2 A):48 S
Dunaif A, Segal KR, Futterweit W, Dobrjansky A (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 28:1165–1174
Eaker ED, Castelli WP (1987) Coronary heart disease and it’s risk factors among women in the Framingham Study. In: Eaker ED, Paker B, Wenger N et al. (eds) Coronary Heart Disease in Women. Haymarket Doyma, New York, p 122
Elveback LR, Connaolly DC, Melton LJ III (1986) Coronary heart disease in residents of Rochester, Minnesota. VII. Incidence, 1950 through 1982. Mayo Clin Proc 61:896–900
Fried LP, Becker DM (1993) Smoking and cardiovascular disease. In: Douglas PS (ed) Cardiovascular Health and Disease in Women. Saunders, Philadelphia, p 217
Grundy SM, Pasternak R, Greenland P et al. (1999) Assessment of cardiovascular risk by use of multiple risk-factor assessment equations: A statement for healthcare professionals from the American Hear Association and the American College of Cardiology. Circulation 100:1481
Hayes SN, Taler SJ (1998) Hypertension in women: current understanding of gen der differences. Mayo Clin Proc 73:157
Heyden S, Heiss G, Bartel AG et al. (1980) Sex differences in coronary mortality among diabetics in Evans County, Georgia. J Chron Dis 33:265–273
Hermanson B, Omenn GS, Kronmal RA et al. (1988) Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease: Results from CASS registry. N Engl J Med 319:1365
Howard BV, Lee ET, Cowan LD et al. (1995) Coronary he art disease prevalence and its relation to risk factors in American Indians: The Strong Heart Study. Am J Epidemiol 142:254–268
Howard BV, Cowan LD, Haffner SM (1997) Women, Diabetes, Lipoproteins, and the Risk for Coronary Heart Disease. In: Forte TM (ed) Hormonal, metabolie, and cellular influences on cardiovascular disease in women. Futura Publishing Company, Armonk/NY, S 262
Jousilahti P, Vartiainen E, Tuomilehto J, Puska P (1999) Sex, age, cardiovascular risk factors, and coronary heart disease: A prospective follow-up study of 14.786 middle-aged men and women in Finland. Circulation 99:1165
Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease: The Framingham study. JAMA 241:2035–2038
Kannel WB, Wilson PWF (1995) Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 155:57
Kaplan NM (1989) The deadly quartet: upper-body obesity, glucose intolerance, hypertryglyceridemia, and hypertension. Arch Intern Med 149:1514
Kushi LH, Fee RM, Folsom AR et al. (1997) Physical activity and mortality in postmenopausal women. JAMA 277:1287
LaRosa JC (1993) Lipoproteins and lipid disorders. In: Douglas PS (ed) Cardiovascular health and disease in women. Saunders, Philadelphia, p 175
LaRosa JC (1997) Triglycerides and coronary risk in women and the elderly. Arch Intern Med 157:961
Laws A, King AC, Haskell WL, Reaven GM (1993) Metabolie and behavioral covariates of high-density lipoprotein cholesterol and triglycerides concentrations in post-menopausal women. J Am Geriatr Soc 41:l289–1294
Lemaitre RN, Heckbert SR, Psaty BM et al. (1995) Leisure-time physical activity and the risk of nonfatal myocardial infarction in postmenopausal women. Arch Intern Med 155:2302
Manson JE, Colditz GA, Stampfer MJ et al. (1991) A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.Arch Intern Med 151:1141–1147
Manson JE, Hu FB, Rich-Edwards JW et al. (1999) A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med 341:650
Miller VT (1994) Lipids, lipoproteins women and cardiovascular disease. Artherosclerosis 108:S73
Mosca L, Grundy SM, Judelson D et al. (1999) Guide to preventative cardiology for women. Circulation 99:2480
Mosca L, Manson JE, Sutherland SE et al. (1997) Cardiovascular disease in women: A statement for healthcare professionals from the AHA. Circulation 96:2468
National Cholesterol Education Program (1994) Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation 89:1329–1445
Ridker PM, Buring JE, Shih J et al. (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731–733
Ridker PM, Rifai N, Pfeffer MA et al. (1999) Long-term effects of Pravastatin on plasma concentration of C-reactive protein. Circulation 100:230–235
Ridker PM, Hennekens CH, Buring JE et al. (2000) C-reactive protein and other markers of inflammation in tlIe prediction of cardiovascular disease in women. N Engl J Med 342:836–843
Rimm EB, Willett WC, Hu FB et al. (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279:359–364
Robinson S, Henderson AD, Gelding SV et al. (1996) Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol 44:277–284
Rosenberg L, Kaufman DW, Helmrich SP, Miller DR, Stolley PD, Shapiro S (1985) Myocardial infarcation and cigarette smoking in women younger than 50 years of age. JAMA 253(20): 2965–2969
Second Joint Task Force of European and other societies on Coronary Prevention (1998) Prevention of coronary heart disease in clinical practice. Eur Heart J 19:1434–1503
Shapiro S, Sloane D, Rosenberg L et al. (1979) Oral contraceptive use in relation to myocardial infarction. Lancet 1:743
Shlipak MG, Simon JA, Vittinghoff E et al. (2000) Estrogen and progestin, lipoprtein (a), and the risk of recurrent coronary heart disease events after menopause. JAMA 283:1845–1852
Stampfer MJ, Malinow MR, Willett WC (1998) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in U. S. physicians. JAMA 279:359–364
Talbott E, Guzick D, Clerici A et al. (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Aterioscler Thromb Va sc Biol 15:821–826
Van Poppel G, Kardinaal A, Princen H, Kok FJ (1994) Antioxidants and coronary heart disease. Ann Med 26:429–434
Walsh JME (1999) Lipids. In: Charney P (ed) Coronary artery disease in women: What all physicians need to know.American College of Physician Press, Philadelphia, p 1041
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
von der Lohe, E. (2002). Kardiovaskuläre Risikofaktoren und deren Bedeutung für die Entstehung der koronaren Herzkrankheit bei der Frau. In: Koronare Herzkrankheit bei Frauen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56041-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-56041-5_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42051-4
Online ISBN: 978-3-642-56041-5
eBook Packages: Springer Book Archive